UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	December 26, 2024 4:00 P.M.

Form:	S-3
CIK: 0001662774 Company Name: Quince Therapeutics, Inc. File Number: 333-283897